CNVs have been reported to encompass genes known to be involved in breast cancer susceptibility, including BRCA1 and BRCA2, and therefore may similarly affect other genes involved in breast cancer-related pathways [12]. This evidence concerns the gene BRCA2 and breast carcinoma.